APA (7th ed.) Citation

Pu, X., Zhou, Y., Wang, J., & Wu, L. (2025). Immune Checkpoint Inhibitor‐Based Therapy as the First‐Line Treatment for Advanced Non‐Small Cell Lung Cancer: Efficacy, Challenges, and Future Perspectives. Wiley.

Chicago Style (17th ed.) Citation

Pu, Xingxiang, Yu Zhou, Jingyi Wang, and Lin Wu. Immune Checkpoint Inhibitor‐Based Therapy as the First‐Line Treatment for Advanced Non‐Small Cell Lung Cancer: Efficacy, Challenges, and Future Perspectives. Wiley, 2025.

MLA (9th ed.) Citation

Pu, Xingxiang, et al. Immune Checkpoint Inhibitor‐Based Therapy as the First‐Line Treatment for Advanced Non‐Small Cell Lung Cancer: Efficacy, Challenges, and Future Perspectives. Wiley, 2025.